Dalton Investments Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 166.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,400 shares of the medical equipment provider’s stock after acquiring an additional 1,500 shares during the period. Intuitive Surgical accounts for about 0.6% of Dalton Investments Inc.’s investment portfolio, making the stock its 17th largest holding. Dalton Investments Inc.’s holdings in Intuitive Surgical were worth $1,189,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $26,000. Global Financial Private Client LLC boosted its holdings in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical in the first quarter worth $26,000. Finally, LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical during the first quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock opened at $470.08 on Monday. The stock’s fifty day moving average is $516.52 and its 200 day moving average is $528.23. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a market cap of $168.51 billion, a P/E ratio of 65.56, a P/E/G ratio of 4.93 and a beta of 1.59.
Insider Activity at Intuitive Surgical
In other news, insider Gary S. Guthart sold 7,893 shares of the company’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the transaction, the insider owned 13,187 shares of the company’s stock, valued at $6,575,565.68. This represents a 37.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,881 shares of company stock worth $7,920,634. 0.70% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the stock. UBS Group upped their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating and cut their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Piper Sandler reiterated an “overweight” rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Truist Financial lifted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $595.95.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Ride Out The Recession With These Dividend Kings
- 3 Dividend Stocks Raising Payouts—and Backing It Up With Results
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Stocks With Monopoly Power—and Minimal Competition
- Earnings Per Share Calculator: How to Calculate EPS
- Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.